Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Serum Profile of Inflammatory Factors, Immune and Angiogenic in Temporal Lobe Epilepsy

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
University Hospital, Montpellier
ClinicalTrials.gov Identifier:
NCT01563627
First received: March 9, 2012
Last updated: May 31, 2016
Last verified: May 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2013
  Primary Completion Date: September 2013 (Final data collection date for primary outcome measure)